- ESVONC
- Avenue Ceramique 222
- 6221 KX Maastricht
- The Netherlands
- Tel: +31(0)43 325 05 21
- office@esvonc.com
Please find here the scientific program for the 2024 ESVONC congress in Bucharest.
There will be no live streaming.
The Nurses program on Friday 24th & Saturday 25th May is visible under the separate tab in the top menu.
The Grand Hotel Bucharest will be the venue for the 2024 ESVONC Congress.
Residents' Workshop | ||
15.00-15.45 | Making the grade: A review of tumor grading systems in veterinary onco-pathology for common to rare tumor types | Giancarlo Avallone |
15.45-16.30 | Going above and beyond: How may an individual patient's tumor be analyzed and reported in the future? Is there such a thing as personalized pathology? | Giancarlo Avallone |
16.30-17.00 | COFFEE BREAK | |
17.00-17.45 | Targeted therapies and iNKT cells: Innovative Engineering in Human and Canine Immunotherapy to meet Ever-Emerging Challenges in Cancer Care | Nicola Mason |
17.45-18.15 | Targeted therapies in Cancer Management: Monoclonal antibodies and checkpoint inhibition harness immune power to eliminate cancer | Nicola Mason |
08.00-09.00 | REGISTRATION OPENS | |
08.45-09.00 | Welcome ESVONC to Bucharest! | Anca Cristea |
RADIATION THERAPY |
||
09.00-09.30 | Introduction and General Principles and Limitations about abdominal RT | Valerie Poirier |
09.30-10.15 | Abdominal SBRT and hypofractionation in humans – possible implications for animal radiotherapy | Nuno Pimentel MD |
10.15-10.45 | COFFEE BREAK | |
10.45-11.15 | Abdominal RT in veterinary practice : genito-urinary and other indications | Michael Nolan |
11.15-11.45 | ASAC the Zurich Experience | Carla Rohrer |
11.45 - 12.15 |
PANEL DISCUSSION chaired by Dr Valerie Poirier |
All speakers |
12.15-14.15 | Lunch & Poster Session | |
14.15-14.45 |
Sponsored talk by Varian (TBC)
|
|
RT Abstracts | ||
15.00-15.15 | Improvement of neurodisability scores in dogs with intracranial neoplasia treated with two randomly assigned radiation protocols | Felicitas Czichon |
15.15-15.30 | Acute toxicity associated with a daily 5-fraction stereotactic radiation therapy protocol for confirmed or MRI-presumed canine intracranial meningioma | James Elliott |
15.30-15.45 | Preliminary insights from quantitative analysis of pituitary tumour response to definitive radiotherapy in dogs: comparison of three measurement methods | Tommaso Pilla |
15.45-16.00 | A cyclical, palliative-intent hypofractionated radiotherapy protocol (‘Quad-shot’) for the treatment of canine nasal tumours | Ines Cabral |
16.00-16.30 | COFFEE BREAK | |
RT Abstracts | ||
16.30-16.45 | Can pre-treatment biopsy characteristics predict early treatment failure in feline nasal lymphoma treated with radiation therapy? | Valerie Poirier |
16.45-17.00 | Comparison of two radiotherapy protocols for the palliative treatment of canine nasal adenocarcinoma delivered at a single institution | Alison Hayes |
17.00-17.15 | Efficacy and tolerance of short cycles of palliative radiotherapy in advanced anal sac adenocarcinomas in dogs | Mario Militi |
17.15-17.30 | Long Term Follow-up of dogs with Anal Sac Gland Carcinoma (ASGC) Receiving a Moderate Total Dose 10 Fraction Adjuvant Radiation Protocol 32-36 Gy | Sarah L Mason |
17.30-18.00 |
ESVONC RESEARCH FUND PRESENTATION |
ESVONC CRF Committee |
19.00-21.00 |
Welcome Reception in Bucharest! venue: PALACE OF THE PARLIAMENT (Izvor street, no. 2-4) kindly sponsored by Hill's Pet Nutrition & Varian Medical Systems
|
08.00-09.00 |
REGISTRATION Breakfast round table DeepscanDx (TBC) |
|
TARGETED THERAPIES | ||
09.00-09.45 | Comparative approaches to improve efficacy and availability of adoptive cell therapies for canine cancer patients | Nicola Mason |
09.45-10.30 | The hunt for correlative biomarkers of immunotherapeutic response - knowing who will respond before treatment | Nicola Mason |
10.30-11.00 | COFFEE BREAK | |
11.00-11.45 | Immune Checkpoint inhibition: The human experience and Pathways to Veterinary Applications | David Vail |
11.45-12.30 | Novel treatments of metastatic solid tumors: from oligometastatic to polymetastatic states | David Vail |
12.30-13.00 | PANEL DISCUSSION | All speakers |
13.00-14.30 | Lunch | |
13.00-14.30 |
Radiation Oncology Specialty Seminar (for ECVDI RO and ECVIM RO only): Machine and Patient-Specific Quality Control in Radiotherapy: Technical and Physical Aspects, and Impact on Daily Clinical Practice and Complication-Free Tumor Control
|
Sergejs Unterkirhers |
Oral Abstracts | ||
14.30-14.45 | Tonsillar squamous cell carcinoma in 10 dogs treated with definitive-intent radiation therapy – preliminary data | Ana Rejec JenĨek |
14.45-15.00 | Radiation therapy on macroscopic thyroid tumors: a retrospective study | Carlotta Marie Ahrens |
15.00-15.15 | Prevalence, distribution and prognostic impact of metastatic site in canine patients affected by splenic hemangiosarcoma | Chiara Catalucci |
15.15-15.30 | Vinorelbine for the treatment of histiocytic sarcoma: clinical response and toxicity profile in 18 dogs | Nina Vigevani |
15.30-16.00 | COFFEE BREAK | |
16.00-16.30 |
SPONSORED TALK by CanCan Diagnostics |
|
Oral Abstracts | ||
16.30-16.45 | Pilot study investigating the intravenous administration of monomeric L-asparaginase to dogs with multicentric lymphoma | Vittorio Botta |
16.45-17.00 | Electrochemotherapy for the treatment of canine prostatic carcinoma: preliminary results in nine dogs | Filomena Assunta Amato |
17.00-17.15 | Current recommendations for sentinel lymph node biopsy in canine malignancies: a survey study | Lavinia Elena Chiti |
17.15-17.30 | Evaluation of time to neutropenic nadir in dogs receiving carboplatin: a multicentric retrospective study | Jose Alvarez Picornell |
18.00-... | Evening on your own! |
08.00-09.00 | REGISTRATION | |
Artificial Intelligence Lectures | ||
09.00-09.45 | Artificial Intelligence: What is AI? And what is its current and future relevance to human and veterinary biomedical sciences? | Kevin Wells |
09.45-10.30 |
AI in veterinary oncology: Tumor grading, staging and treatment |
Kevin Wells |
10.30-11.00 | COFFEE BREAK | |
11.00-11.45 | Artificial intelligence in diagnostic imaging: reality or promise? | Tomasso Banzato |
11.45-12.30 | AI in Radiation Oncology | Michael Nolan |
12.30-13.00 | PANEL DISCUSSION chaired by Dr Nicola Mason | All speakers |
13.00-15.00 | Lunch | |
14.00-15.00 | ANNUAL GENERAL MEETING (AGM) | ESVONC members |
15.00-15.30 |
SPONSORED TALK by DeepscanDx (title TBC) |
|
Oral Abstracts | ||
15.30-15.45 | Characterization of the fecal microbiota in dogs with mast cell tumours and comparison with healthy dogs | Catarina Aluai-Cunha |
15.45-16.00 | Multimodal characterization of canine perivascular wall and peripheral nerve sheath tumors | Houria Ech-Cherif |
16.00-16.15 | Looking forward to 2025 ESVONC @ PORTO Presentation | |
16.15-16.45 | COFFEE BREAK | |
Oral Abstracts | ||
16.45-17.00 | Molecular characterization of canine FSA and MFS using spatially defined transcriptomics and proteomics | Daniel Fuchs |
17.00-17.15 | Trametinib inhibits growth of canine oral squamous cell carcinoma | Santiago Peralta |
17.15-17.30 | Comparison of various electrochemotherapy protocols for the treatment of feline cutaneous squamous cell carcinoma | Nicolas Diop |
17.30-17.45 | Microwave ablation in veterinary oncology : a pilot study in 23 patients | David Sayag |
17.45-18.00 | Comparison of MOPP versus LOPP for first-line treatment of canine multicentric T-cell or hypercalcemic lymphoma | Ashley Smith |
20.00-... |
ESVONC's GALA DINNER venue: LINEA / CLOSER TO THE MOON kindly sponsored by |